VS
Varma Srinivasa Rajasekara Rudraraju
About Varma Srinivasa Rajasekara Rudraraju
Data last updated:
Varma Srinivasa Rajasekara Rudraraju is a Managing Director at Aizant Drug Research Solutions Private Limited (since 2005), Director at Aizen Algo Private Limited (since 2017) and Director at Aizen Analytics Services Private Limited (since 2026), and holds 3 more current directorships. The companies operate in Pharma, Business Services and Information Technology. The 2 current companies with reported revenue have a combined latest revenue of ₹195 Cr; the largest is Aizant Drug Research Solutions Private Limited at ₹193 Cr (FY 2023). Earlier, Varma Srinivasa Rajasekara Rudraraju was a Director at Flink Systems Private Limited (2008) and Additional Director at Sarudbhava Formulations Private Limited (2012–2020) and 5 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Aizant Drug Research Solutions Private Limited U24239TG2005PTC048133 | Managing Director | 22 Nov 2005 | 2005 | ₹193 Cr (FY 2023) | Active |
 Aizen Algo Private Limited U72900TG2017PTC115409 | Director | 22 Feb 2017 | 2017 | ₹2.67 Cr (FY 2024) | Active |
 Aizen Analytics Services Private Limited U63999TS2026PTC218011 | Director | 20 Jun 2026 | 2026 | Active | |
| Aizen Sim6 Private Limited U72900TG2021PTC157769 | Director | 09 Dec 2021 | 2021 | Active | |
| Incilia Therapeutics Private Limited U24304TG2017PTC115390 | Director | 21 Feb 2017 | 2017 | Active | |
| Aizant Pharmaceuticals Private Limited U24110AP2015PTC096458 | Director | 08 Apr 2015 | 2015 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Flink Systems Private Limited U72200TG2001PTC038101 | Director | 07 Apr 2008 | 2001 | Strike Off | |
| Sarudbhava Formulations Private Limited U24233TG2012PTC084141 | Additional Director | 12 Nov 2012 | 2012 | Active | |
 Fenix Research Labs Private Limited U24239TG2008PTC059967 | Director | 03 Jul 2008 | 2008 | ₹11.62 Cr (FY 2025) | Active |
| Apramitha Innovations Private Limited U24239TG2020PTC140565 | Director | 02 Jun 2020 | 2020 | ₹2.51 Cr (FY 2024) | Active |
| Vivozant Biosciences Private Limited U01119TG2008PTC058580 | Director | 08 Apr 2008 | 2008 | Strike Off | |
| Sanative Therapeutics Private Limited U73100TG2009PTC065216 | Managing Director | 29 Sep 2009 | 2009 | Strike Off | |
| Kuru Consultants Private Limited U74140AP2001PTC037075 | Director | 19 Jan 2008 | 2001 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Varma Srinivasa Rajasekara Rudraraju
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rudraraju Sneha | 09683892 | Aizant Drug Research Solutions Private Limited , Aizen Algo Private Limited | Director |
| Sanjeev Kumar Sethi | 02168682 | Aizant Drug Research Solutions Private Limited | Director |
| Soumya Rudraraju | 09253303 | Aizant Drug Research Solutions Private Limited | Director |
| Srinivas Kotra | Aizant Drug Research Solutions Private Limited | Company Secretary | |
| Srinivasa Sarma Rani | Aizant Drug Research Solutions Private Limited | Company Secretary | |
| Tirunelveli Padmanabhan Devarajan | 03473633 | Aizant Drug Research Solutions Private Limited | Director |
| Padmaja Rudraraju | 02127522 | Aizen Algo Private Limited , Aizen Sim6 Private Limited and 1 more | Director |
| Ramesh Babu Mattupalli | 08124841 | Aizen Algo Private Limited | Director |
| Usha Balakrishnan Bithunshal | 09135632 | Aizen Algo Private Limited , Aizen Analytics Services Private Limited and 2 more | Director |
| Venkata Subba Raju Rudraraju | 07199943 | Aizant Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Varma Srinivasa Rajasekara Rudraraju
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Varma Srinivasa Rajasekara Rudraraju
Varma Srinivasa Rajasekara Rudraraju currently holds 6 directorships: Aizant Drug Research Solutions Private Limited (Managing Director, since 22 Nov 2005, revenue ₹193 Cr (FY 2023)); Aizen Algo Private Limited (Director, since 22 Feb 2017, revenue ₹2.67 Cr (FY 2024)); Aizen Analytics Services Private Limited (Director, since 20 Jun 2026); Aizen Sim6 Private Limited (Director, since 09 Dec 2021); Incilia Therapeutics Private Limited (Director, since 21 Feb 2017); and 1 more.
Varma Srinivasa Rajasekara Rudraraju was first appointed on 22 Nov 2005 as Managing Director at Aizant Drug Research Solutions Private Limited. The most recent appointment on record is 20 Jun 2026 at Aizen Analytics Services Private Limited.
The 2 current companies of Varma Srinivasa Rajasekara Rudraraju that report revenue have a combined latest revenue of ₹195 Cr: Aizant Drug Research Solutions Private Limited ₹193 Cr (FY 2023); Aizen Algo Private Limited ₹2.67 Cr (FY 2024).
Varma Srinivasa Rajasekara Rudraraju held 7 earlier board appointments: Flink Systems Private Limited (Director, 07 Apr 2008 to 30 Oct 2008); Sarudbhava Formulations Private Limited (Additional Director, 12 Nov 2012 to 26 Aug 2020); Fenix Research Labs Private Limited (Director, 03 Jul 2008 to 30 Aug 2008); Apramitha Innovations Private Limited (Director, 02 Jun 2020 to 26 Aug 2020); Vivozant Biosciences Private Limited (Director, from 08 Apr 2008); and 2 more.
The current boards of Varma Srinivasa Rajasekara Rudraraju's companies include Rudraraju Sneha (Aizant Drug Research Solutions Private Limited), Sanjeev Kumar Sethi (Aizant Drug Research Solutions Private Limited), Soumya Rudraraju (Aizant Drug Research Solutions Private Limited), Srinivas Kotra (Aizant Drug Research Solutions Private Limited), Srinivasa Sarma Rani (Aizant Drug Research Solutions Private Limited), Tirunelveli Padmanabhan Devarajan (Aizant Drug Research Solutions Private Limited), among others.